NA Selank Amidate

NA Selank Amidate

NA Selank Amidate

NA Selank Amidate exhibits improved molecular stability and in vivo pharmacokinetic profile through a double-modification strategy of N-terminal acetylation and C-terminal amidation based on the original structure of Selank.

 

SKU: 198884 Catagóir:
Roinn do ghrá

NA Selank Amidate exhibits improved molecular stability and in vivo pharmacokinetic profile through a double-modification strategy of N-terminal aicéitilithe and C-terminal amidation based on the original structure of Sealann.

This results in an increased half-life, enhanced bacainn fola-inchinn penetration efficiency, and prolonged bioactivity in both molecular and animal models.

Thairis sin, NA Selank Amidate exhibits potent inmunomodulation and anti-stress activity.

Seicheamh

ac-thr-lys-pro-arg-pro-gly-pro-nh2

Uimhir CAS

/

Foirmle Mhóilíneach

C35H60N12O9

Meáchan Móilíneach

792.94

Research Of NA Selank Amidate

1.Retained and Enhanced Efficacy

Éifeachtúlacht-ciallmhar,NA Selank Amidate retains all of the characteristics of Selank, ag rialáil gamma-aminobutyric acid (GABA) neurotransmission in the brain while also modulating the dopaminergic agus serotonergic systems to deliver outstanding imníoch agus antidepressant éifeachtaí.

It also shows better efficacy than Selank in enhancing cognitive and neuroprotective functions, producing pronounced positive effects on learning, memory, and attention.

2.Anxiolytic and Mood-Stabilizing Effects

In a concentration-dependent and subtype-selective manner, NA Selank Amidate allosterically modulates an GABA-A receptor by potentiating the binding efficacy of GABA to its receptor or enhancing chloride ion channel opening efficiency.

This significantly increases the inhibitory tone in key brain circuits, producing marked anxiolytic effects.

Ina theannta sin, the side effects of this anxiolytic action are significantly milder than those of conventional anxiolytic drugs, making NA Selank Amidate a more attractive mood-stabilizing compound.

3.Cognitive Enhancement and Neuroprotection

NA Selank Amidate directly activates BDNF gene transcription by inducing fosfarylation of the promoter-located CREB transcription factor and acetylation of histone H3, increasing BDNF mRNA levels 3.2-fold in hippocampal dentate gyrus granule cells and prefrontal cortical pyramidal neurons and protein secretion 2.8-fold within 24 uair an chloig.

This activates the TrkB receptor signaling pathway downstream, inducing the Ras-MAPK and PI3K-Acht cascade to increase dendritic spine density by 39%, upregulate synaptophysin expression by 45%, and restore LTP amplitude to baseline.

This successfully prevents stress-induced hippocampal neuronal injury and cognitive decline, demonstrating distinct neuroprotective properties.

4.Immunomodulatory and Anti-Stress Effects

NA Selank Amidate is a competitive inhibitor of enkephalin-degrading enzyme, protecting endogenous opioid peptides from hydrolysis and thereby elevating their levels, while it inhibits LPS (lipopolysaccharide)-induced expression of pro-inflammatory cítocíní lena n-áirítear IL-6 agus TNF-α by 40–60% in astrocytes.

NA Selank Amidate also represses NF-κB nuclear translocation by interfering with the recruitment of MyD88 adaptor protein, providing protective regulation in the neuroinflammatory microenvironment.

COA

HPLC

MS

(1) Ba mhaith linn, c. R.; Bán, c. M. Gníomhairí Támhacháin-Hypnotic a Bíonn tionchar acu ar Ghabhdóirí Aigéad Gáma-Aminobutyric: Fócas ar Flunitrazepam, Aigéad Gáma-Hidroxybutyric, Phenibut, agus Selank. J Clin Pharmacol 2021, 61 Supl 2, S114-S128. DOI: 10.1002/jcph.1922 From NLM M

(2) Rud bocht, A.; Kolomin, T.; Andreeva, L.; Bondarenko, E.; Míosaedov, N.; Slominsky, p.; Shadrina, M. Feabhsaíonn Peptide Selank Éifeacht Diazepam chun Imní a Laghdú i gCoinníollacha Strus Éadrom Ainsealach Dothuartha i bhFrancaigh. iompar Neurol 2017, 2017, 50910

(3) Bioráin, L. G.; Nadorova, A. V.; Antipova, T. A.; Kruglov, S. V.; Kudrin, V. S.; Durnev, A. D. Sealann, Analógach Peptide de Tuftsin, Cosnaíonn sé in aghaidh Lagú Cuimhne de bharr Eatánól trí Ábhar BDNF a Rialáil sa Chortéis Hippocampus agus Prefrontal

(4) Bioráin, L. G.; Nadorova, A. V.; Seedenin, S. b. Cuireann Selank cosc ​​ar Hipiríogaireacht arna Spreagadh ag Eatánól agus Léiriú Íogaireacht Iompraíochta i lucha DBA/2. Bull Exp Biol Med 2016, 162 (1), 56-59. DOI: 10.1007/s10517-016-3544-6 From NLM Medline.

(5) Costas, N. V.; Sokolov, O.; Gabaeva, M. V.; Grivennikov, mé. A.; Andreeva, L. A.; Miasoedov, N. F.; Zozulia, A. A. [Cuireann Semax agus selank bac ar einsímí díghrádaithe enkephalin ó serum daonna]]. Bioorg Khim 2001, 27 (3), 180-183. DOI: 10.1023/a:10113730028

(6) Níl a fhios agam, G. G.; Teleshova, E. S.; Bochkarev, V. K.; Koschelev, V. V.; Sínyakova, T. S. P.3.036 Selank imníoch úrscéal: Torthaí trialacha cliniciúla Chéim II. Neuropsychopharmacology Eorpach 2005, 15, S159-S160. DOI: 10.1016/s0924-977x(05)80332-3.

(7) Slominsky, p. A.; Shadrina, M. mé.; Kolomin, T. A.; Stavrovskaya, A. V.; Filatova, E. V.; Andreeva, L. A.; Illarioshkin, S. N.; Míosaedov, N. F. Bíonn tionchar ag peptides semax agus selank ar iompar francaigh a bhfuil parkinsonism cosúil le PD spreagtha 6-OHDA acu. Go dtí Biol Sc

(8) Sollertinskaja, T. N.; Shorokhov, M. V.; Míosaedov, N. F. Éifeachtaí cerebroprotective Semax agus Selank i primates ag cineálacha éagsúla neacróis. Iris Idirnáisiúnta na Síceifiseolaíochta 2008, 69 (3). DOI: 10.1016/j.ijpsycho.2008.05.356.

Seicheamh:

ac-thr-lys-pro-arg-pro-gly-pro-nh2

CAS:

/

M.W:

792.94 g/mol

Baile Cuardach Whatsapp Seirbhísí Táirge